Antihyperalgesic Effects of Ethosuximide and Mibefradil, T-type Voltage Activated Calcium Channel Blockers, in a Rat Model of Postoperative Pain
![]() |
Shinn, Helen Ki
(Department of Anesthesiology and Pain Medicine, College of Medicine, Inha University)
Cha, Young Deog (Department of Anesthesiology and Pain Medicine, College of Medicine, Inha University) Han, Jeong Uk (Department of Anesthesiology and Pain Medicine, College of Medicine, Inha University) Yoon, Jeong Won (Department of Anesthesiology and Pain Medicine, College of Medicine, Inha University) Kim, Boo Seong (Bucheon Pain Clinic) Song, Jang Ho (Department of Anesthesiology and Pain Medicine, College of Medicine, Inha University) |
1 | Kostyuk PG, Molokanova EA, Pronchuk NF, Savchenko AN. Verkhratsky AN: Different action of ethosuximide on low- and high-threshold calcium currents in rat sensory neurons. Neuroscience 1992; 51: 755-8 DOI ScienceOn |
2 | Hennsmeyer K, Mishra S, Miyagawa K, Minshall R: Physiologic and pathophysiologic relevance of T-type calcium-ion channels: potential indications for Tctype calcium antagonists. Clin Ther 1997; 19(5uppl A): 18-26 DOI ScienceOn |
3 |
Ertel SI, Clozel JP: Mibefradil (Ro 40-5967): the first selective T-type |
4 | Flatters SJ, Bennett GJ: Ethosuximide reverses paclitaxeland vincristine-induced painful peripheral neuropathy. Pain 2004; 109: 150-61 DOI ScienceOn |
5 | White DM, Cousins MJ: Effect of subcutaneous administration of calcium channel blockers on nerve injury-induced hyperalgesia. Brain Res 1998; 801: 50-8 DOI ScienceOn |
6 | Diaz A, Dickenson AH: Blockade of spinal N- and P-type, but not L-type, calcium channels inhibits the excitability of rat dorsal hom neurones produced by subcutaneous formalin inflammation. Pain 1997; 69: 93-100 DOI ScienceOn |
7 | Carbone E, Lux HD: A low voltage-activated, fully inactivating Ca channel in vertebrate sensory neurones. Nature 1984; 310: 501-2 DOI ScienceOn |
8 | Bertolino M, Uinas RR: The central role of voltageactivated and receptor-operated calcium channels in neuronal cells. Annu Rev Phannacol Toxicol 1992; 32: 399-421 DOI ScienceOn |
9 | Anwyl R: Modulation of venebrate neuronal calcium channels by transmitters. Brain Res Brain Res Rev 1991; 16: 265-81 DOI ScienceOn |
10 |
Matthews EA, Dickenson AH: Effects of ethosuximide, a T-type |
11 | Todorovic SM, Rastogi AJ, Jevtovic-Todorovic V: Potent analgesic effects of anticonvulsants on peripheral thermal nociception in rats. Br J Phannacol 2003; 140: 255-60 |
12 | Han HC, Lee DH, Chung JM: Characteristics of ectopic discharges in a rat neuropathic pain model. Pain 2000; 84: 253-61 DOI ScienceOn |
13 | Matthews EA, Dickenson AH: Effects of spinally delivered N- and P-type voltage-dependent calcium channel antagonists on dorsal hom neuronal responses in a rat model of neuropathy. Pain 2001; 92: 235-46 DOI ScienceOn |
14 | Horvath G, Brodacz B, Holzer-Petsche U: Role of calcium channels in the spinal Iransmission of nociceptive information from the mesentery. Pain 2001; 93: 35-41 DOI ScienceOn |
15 | Jimenez C, Bcurinet E, Leuranguer V, Richard S, Snutch TP, Nargeot 1: Determinants of voltage-dependent inactivation affect mibefradil block of calcium channels. Neuropharmacology 2000; 39: 1-10 DOI ScienceOn |
16 | Todorovic SM, Meyenburg A. Jevtovic-Todorovic V: Mechanical and thermal aminociccprion in rats following systemic administration of mibcfradil, a Tctype calcium channel blocker. Brain Res 2002; 951: 336-40 DOI ScienceOn |
17 | Smith MT, Cabot PJ, Ross FB, Robertson AD, Lewis RJ: The novel N-type calcium channel blocker, AM336, produces potent dose-dependent antinociception after intrathecal dosing in rats and inhibits substance P release in rat spinal cord slices. Pain 2002; 96: 119-27 DOI ScienceOn |
18 | Dogrul A, Gardell LR, Ossipov MH, Tulunay FC, Lai J, Porreca F: Reversal of experimental neuropathic pain by T-type calcium channel blockers. Pain 2003; 105: 159-68 DOI ScienceOn |
19 | Clozel JP, Ertel EA, Ertel SI: Discovery and main pharmacological properties of mibefradil (Ro 40-5967), the first selective Tvtype calcium channel blocker. J Hypenens Suppl 1997; 15: 17-25 |
20 | Huguenard JR: Low-threshold calcium currents in central nervous system neurons. Annu Rev Physiol 1996; 58: 329-48 DOI ScienceOn |
21 | Shannon HE, Eberle EL, Peters SC: Comparison of the effects of anticonvulsant drugs with diverse mechanisms of action in the formalin test in rats. Neurophannacology 2005; 48: 1012-20 DOI ScienceOn |
22 | Todorovic SM, Jevtovic-Todorovic V, Meyenburg A, Mennerick S, Perez-Reyes E, Romano C. et al: Redox modulation of T-type calcium channels in rat peripheral nociceptors. Neuron 2001; 31: 75-85 DOI ScienceOn |
23 | Brennan TJ, Vandermeulen EP, Gebhan GF: Characterization of a rat model of incisional pain. Pain 1996; 64: 493-501 DOI ScienceOn |
24 | Liu X, Eschenfelder S, Blenk KH, lanig W, Habler H: Spontaneous activity ofaxotomized afferent neurons after L5 spinal nerve injury in rats. Pain 2000; 84: 309-18 DOI ScienceOn |
25 | Chaplan SR, Pogrel JW, Yaksh TL: Role of voltagedependent calcium channel subtypes in experimental tactile allodynia. J Phannacol Exp Ther 1994; 269: 1117-23 |
26 | Carbone E. Lux AD: A low voltage-activated calcium conductance in embryonic chick sensory neurons. Biophys J 1984; 46: 413-8 DOI ScienceOn |
27 |
Ertel SI, Enel EA: Low-voltage-activated T-type |
28 | Lee DS, Goodman S, Dean DM, Lenis J , Ma P, Gervais PB, et al: Randomized comparison of T-type versus L-type calcium-channel blockade on exercise duration in stable angina: results of the posicor reduction of ischemia during exercise (PRIDE) trial. Am Heart J 2002; 144: 60-7 DOI ScienceOn |
29 | Storkson RV, Kjorsvik A, Tjolsen A, Hole K: Lumbar catheterization of the spinal subarachnoid space in the rat. J Neurosei Methods 1996; 65: 167-72 DOI ScienceOn |
30 | Banon ME, Eberle EL, Shannon HE: The antihyperalgesic effects of the T-type calcium channel blockers ethosuximide, trimethadione, and mibefradil. Eur J Phannacol 2005; 521: 79-85 DOI |
![]() |